Explore more publications!

Africa News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.

Press releases published on February 5, 2026

Bright Pattern and Xceed Announce Partnership to Deliver AI-Powered, Omnichannel Contact Center Solutions
ITPS Canada signs historic Memorandum of Understanding with Ethiopian Air Force
Hantec Markets Limited Named Official Partner of UFC Across Asia Pacific in Multiyear Agreement
A MMEC 2026 abrirá com um diálogo de alto nível sobre recursos naturais e crescimento regional inclusivo em Moçambique
Qubittron and TGTS Africa Form Regional Partnership to Deliver SAP and AI Modernization Across West Africa
MMEC26 to Launch with High-Level Dialogue on Transforming Mozambique’s Natural Resources into Inclusive, Regional Growth
Cornhole Market Outlook: Technological Advancements, Investment Opportunities and Global Dynamics By 2033 | BAGGO, Himal
ExGen Resources Announces Results of Exploration on the Southmore Project in the Golden Triangle
DPM Metals Extends Chelopech Mine Life to Ten Years; Provides Updated Mineral Reserve and Resource Estimate and Life of Mine Plan
Namib Minerals Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Requirement
Kingfisher Metals Announces C$20 Million Bought Deal Financing
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March
Zivra AI Launches Real-Time Business Health and Financial Intelligence for SMEs
Century Aluminum Sets Date for Fourth Quarter 2025 Earnings Announcement
XT Exchange Launches Futures Auto-Earn With Dual Rewards Campaign, Enhancing Daily Yield and Trading Flexibility for Futures Users
Erdene Announces Closing of $25 Million Bought Deal Private Placement
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
ADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions